Skip to main content

Ivermectin

ADVERTISEMENT
Identification
Molecular formula
C48H74O14
CAS number
70288-86-7
IUPAC name
4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one
State
State

At room temperature, ivermectin is in a solid state. It is not soluble in water but can dissolve in organic solvents such as ethanol, methanol, and propylene glycol.

Melting point (Celsius)
155.00
Melting point (Kelvin)
428.15
Boiling point (Celsius)
220.00
Boiling point (Kelvin)
493.15
General information
Molecular weight
875.10g/mol
Molar mass
875.1020g/mol
Density
1.2300g/cm3
Appearence

Ivermectin is typically a white to yellowish-white powder, often described as crystalline in form. It is known for its stability, yet should be protected from excessive heat and moisture to maintain its effectiveness.

Comment on solubility

Solubility of 4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one

The compound 4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one with the chemical formula C48H74O14 exhibits distinct solubility properties that can be influenced by various factors.

Properties Influencing Solubility:

  • Polarity: The presence of multiple polar functional groups, such as methoxy and butoxy, suggests that the compound may show varying levels of solubility in polar solvents.
  • Hydrophobic Character: The significant alkyl chains in the structure hint at hydrophobic characteristics, which might reduce its solubility in water but could enhance solubility in organic solvents.
  • Temperature: Like many organic compounds, the solubility of this compound can increase with rising temperatures, making it more soluble in heated solvents.

This compound is likely insoluble or only slightly soluble in water, predominantly favoring solubility in organic solvents such as ethanol or dimethyl sulfoxide (DMSO). As described, solubility is a complex interplay of structure and environmental conditions and is crucial for the compound's application in various chemical processes.

Interesting facts

Interesting Facts about 4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one

This fascinating compound, known as 4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one, belongs to the class of imidazolidinones, which are characterized by their unique five-membered ring structures containing both nitrogen and carbon atoms. Researchers in the field of organic chemistry have been particularly intrigued by this compound for several reasons:

  • Diverse Applications: This compound may play significant roles in pharmaceuticals, particularly in developing new drugs targeting various diseases owing to its structural complexity.
  • Functional Groups: The presence of butoxy and methoxy groups enhances the compound's solubility and reactivity, making it an interesting candidate for synthetic derivatives.
  • Biological Activity: Compounds with imidazolidinone structures have been investigated for their potential biological activities, including anti-inflammatory and antimicrobial properties, suggesting that this compound could be a promising lead in medicinal chemistry.
  • Synthetic Pathways: The synthesis of this compound can involve various reaction strategies such as nucleophilic substitution and cyclization, providing chemistry students with valuable insights into reaction mechanisms.

As scientist Albert Einstein once said, "The important thing is not to stop questioning." This reflects the ongoing inquiries regarding 4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one as researchers continue to explore its full potential and applications across different fields.

In summary, 4-[(3-butoxy-4-methoxy-phenyl)methyl]imidazolidin-2-one is quite more than just a combination of elements; it represents the intricate dance of organic chemistry, illustrating how modifications in structure can lead to a wealth of possibilities in research and development.

Synonyms
RO 20-1724
29925-17-5
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
Ro20-1724
4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one
4-[(3-butoxy-4-methoxyphenyl)methyl]imidazolidin-2-one
ro-20-1724
DIW6F13QW2
2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-, (+-)-
Ro 20 1724
CHEMBL18701
2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-
DTXSID80952376
ROCHE 20-1724
(+-)-4-((3-butoxy-4-methoxyphenyl)methyl)-2-imidazolidinone
RO-20-174
RO-201724
R 020-1724
Ro 20-1724; Ro 20-174; Roche 20-1724
DL-4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE
Ro 201724
SR-01000075647
UNII-DIW6F13QW2
keratan sulfate I
Keratan sulphate I
Ro 1724
Spectrum_001840
Keratan sulfuric acid I
Keratan sulphuric acid I
Spectrum3_001826
4-(3-butoxy-4-methoxy-benzyl)imidazolidin-2-one
Lopac0_000204
BSPBio_001358
BSPBio_002560
BSPBio_003471
KBioGR_000078
KBioSS_000078
KBioSS_002345
MLS000859915
SPECTRUM2300287
GTPL5258
SCHEMBL1022716
BCBcMAP01_000185
KBio2_000078
KBio2_002342
KBio2_002646
KBio2_004910
KBio2_005214
KBio2_007478
KBio3_000155
KBio3_000156
KBio3_002975
CHEBI:111173
Bio2_000078
Bio2_000558
DTXCID001380469
HMS1361D20
HMS1791D20
HMS1989D20
HMS2231O19
HMS3260J09
HMS3266M13
HMS3370M21
HMS3402D20
HMS3411I15
HMS3675I15
STR08002
Tox21_500204
BDBM50010981
MFCD00077397
AKOS024281352
CCG-204299
FR75165
LP00204
SDCCGSBI-0050192.P002
IDI1_033828
NCGC00015166-03
NCGC00015166-04
NCGC00015166-05
NCGC00015166-06
NCGC00015166-07
NCGC00015166-08
NCGC00015166-09
NCGC00015166-13
NCGC00024577-02
NCGC00024577-03
NCGC00024577-04
NCGC00024577-05
NCGC00024577-06
NCGC00024577-07
NCGC00260889-01
DA-77500
RO201724
SMR000326776
HY-100927
CS-0020598
EU-0100204
B 8279
G12263
M02450
4-(3-Butyl-4-methoxy-benzyl)-imidazolidin-2-one
4-(3-Butoxy-4-methoxy-benzyl)-imidazolidin-2-one
SR-01000075647-1
SR-01000075647-3
BRD-A07207424-001-04-1
BRD-A07207424-001-09-0
BRD-A07207424-001-13-2
Q27893950
4- (3-BUTOXY-4-METHOXYBENZYL)IMIDAZOLIDIN-2-ONE
4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one, solid
4-[(3-Butoxy-4-methoxyphenyl)methyl]-2-imidazolidione
Ro-20-1724 - CAS 29925-17-5
2-Imidazolidinone,4-[(3-butoxy-4-methoxyphenyl)methyl]-
(Ro 20-1724)4-(3-Butoxy-4-methoxy-benzyl)-imidazolidin-2-one
4-(3-Butoxy-4-methoxy-benzyl)-imidazolidin-2-one(Ro 20-1724)